Skip to content

Abbott ABT Enterprise value

Enterprise value at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$58.42B-29.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Boston Scientific logo
Boston ScientificBSX
$141.04B-1.0%
DexCom logo
DexComDXCM
$23.19B-10.8%
Edwards Lifesciences logo
Edwards LifesciencesEW
$44.42B+11.0%
Medtronic logo
MedtronicMDT
$131.22B-3.2%

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Calculated from Abbott’s reported figures.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's enterprise value?
Abbott (ABT) reported enterprise value of $205.65B in Q1 2026.
How has Abbott's enterprise value changed year-over-year?
Abbott's enterprise value decreased by 13.1% year-over-year, from $236.77B to $205.65B.
What is the long-term trend for Abbott's enterprise value?
Over 4 years (2021 to 2025), Abbott's enterprise value has grown at a 0.9% compound annual growth rate (CAGR), from $910.43B to $945.52B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.